Section Arrow
SGHT.NASDAQ
- Sight Sciences
Quotes are at least 15-min delayed:2026/11/20 17:54 EST
After Hours
Last
 9.87
-0.31 (-3.05%)
Bid
9
Ask
10.19
High 10.18 
Low 9.87 
Volume 3.75K 
Regular Hours (Closed)
Last
 10.18
-0.44 (-4.14%)
Day High 
10.8399 
Prev. Close
10.62 
1-M High
11.595 
Volume 
369.61K 
Bid
9
Ask
10.19
Day Low
9.97 
Open
10.41 
1-M Low
8.09 
Market Cap 
590.25M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 10.71 
20-SMA 10.01 
50-SMA 9.16 
52-W High 11.595 
52-W Low 3.378 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.52/-0.20
Enterprise Value
630.55M
Balance Sheet
Book Value Per Share
0.88
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
79.87M
Operating Revenue Per Share
1.49
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.3233 +0.3433 +0.82%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.65 +0.02 +1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.52 -0.42 -0.42%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.93 +0.021 +2.31%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103.53 +0.53 +0.51%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.